Measuring cancer prevalence in Europe: the EUROPREVAL project.
about
Cancer registries in Europe-going forward is the only optionEstimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry.Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap.The increase in cancer prevalence and hospital burden in Western Australia, 1992-2011.Total and partial cancer prevalence in the adult French population in 2008Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other?Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability.Advancing comparative studies of patterns of care and economic outcomes in cancer: challenges and opportunitiesA population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry.Global estimates of cancer prevalence for 27 sites in the adult population in 2008.Projections of cancer prevalence by phase of care: a potential tool for planning future health service needs.Cancer prevalence in Italy: an analysis of geographic variability.Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case-control study.Health status of older cancer survivors-results of the PolSenior study.Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis.Cancer prevalence in European registry areas
P2860
Q26746893-78DC484B-D3FA-4E29-A874-E6594F5AE586Q31111112-829ECB8F-9344-4956-A6BF-BD26FEFD8C9AQ34156439-2E7EF3AF-BCB9-45A4-9E81-31964A365EF6Q34360643-B43B10BE-0FAA-42D5-9F29-76B7693100C4Q34986518-16BD6ED2-554E-4FFC-9FEC-3811C3936AFFQ35204233-3D19345A-2CB8-400E-9A95-B5BBF77469DEQ36948729-D35932D6-2AFE-44A6-B8D3-82CB8B99F6DBQ37003341-F9D06E61-AB9A-4C55-A427-38B5E7FE0C18Q37383668-4F6B0FD9-F612-4337-B59F-35750CBC78A2Q37723828-92C37A0B-6835-40AE-95CC-767D3EC2F4FFQ38920305-A766B238-B77C-4934-826D-85D24E143660Q39371265-BFC6B9EA-195A-4DB3-AC23-05C83F016D6CQ44886129-00C3ED8E-25E3-4864-BB21-FCFBB692B5FDQ46524658-951B0FEE-B89E-49CD-9C26-C2D09BB2D0B0Q47557445-C87FDEB4-8515-4727-9787-5AAD71DF6866Q48788166-9A3139FB-7BB3-4721-A8F8-0A8E78971031Q57037907-80C9B91D-A74A-4078-8AEF-5F4089F1708B
P2860
Measuring cancer prevalence in Europe: the EUROPREVAL project.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@ast
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@en
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@nl
type
label
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@ast
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@en
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@nl
prefLabel
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@ast
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@en
Measuring cancer prevalence in Europe: the EUROPREVAL project.
@nl
P2093
P2860
P50
P356
P1433
P1476
Measuring cancer prevalence in Europe: the EUROPREVAL project
@en
P2093
EUROPREVAL Working Group
I Corazziari
R Capocaccia
P2860
P304
P356
10.1093/ANNONC/MDF152
P577
2002-06-01T00:00:00Z